Singapore: Executive director of DIA, Mr Paul Pomerantz is quitting his position effective March 3, 2013, to assume the ...
Dotmatics, a UK-based provider of scientific informatics solutions and services, announced its extension of operations t...
Singapore: An international team of researchers at German Center for Neurodegenerative Diseases (DZNE) and Tokyo Institu...
Singapore: Japan-based drugmaker Otsuka Pharmaceutical's vasopressin V2 receptor antagonist Samsca 7.5mg tablets has bee...
Australian biotechnology company, Phosphagenics Limited has expanded its existing license option agreement, with one of ...
Singapore: Japan-based Pharma Takeda has increased its efforts for strategic investments in Israel through its Silicon V...
US-based provider of cloud-based solutions for clinical research in life sciences, Medidata has announced that its cloud...
Singapore: Japan's pharmaceutical company, Eisai, has established its presence in China by setting up a holding firm, Ei...
Singapore: The High Energy Accelerator Research Organization (KEK) and Japan-based Astellas Pharma have concluded an agr...
Singapore: Transcu Group, a life sciences company engaged in the research, development and commercialization of cutting-...
Singapore: Japan headquartered Takeda Pharmaceutical has expanded its operations in Singapore in order to focus on emerg...
Singapore: GlaxoSmithKline has submitted a regulatory application to the Japanese Ministry of Health, Labour and Welfare...
Belgium-based Ion Beam Applications S.A. (IBA) and Japanese major Toshiba Corporation have signed a global collaboration...
Singapore: The European Commission has amended the marketing authorization for Xtandi, manufactured by the Japanese drug...
Takeda Pharmaceutical Company Limited has announced the appointment of James Kehoe as Takeda's new Chief Financial Offic...
Singapore: Dr Theodore Friedmann, MD, professor in the department of pediatrics at University of California, San Diego S...
The press release indicated that Immutep is a French company and is a 100 percent subsidiary of Prima BioMed. Immutep de...
Singapore: US-based Egalet has entered into a definitive collaboration and license agreement with Japan-based Shionogi f...
